Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients

Abstract Background Transaminase and creatinine elevations have been well described in adults treated with remdesivir for COVID-19. It is hypothesized that a similar safety profile exists in children with COVID-19 treated with remdesivir, but available data are limited, especially in children < 12 m...

Description complète

Détails bibliographiques

Auteurs principaux:	Brittany Player, Anna R. Huppler, Amy Y. Pan, Melodee Liegl, Peter L. Havens, Katie Ray, Michelle Mitchell, Kelly Graff
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-09-01
Collection:	BMC Infectious Diseases
Sujets:	Children COVID-19 Anti-viral Side effects Remdesivir
Accès en ligne:	https://doi.org/10.1186/s12879-024-09833-9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!